(Q39029626)

English

Treatment-Resistant Schizophrenia: Treatment Response and Resistance in Psychosis (TRRIP) Working Group Consensus Guidelines on Diagnosis and Terminology

scientific article published on 6 December 2016

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

8 September 2017

1 reference

Europe PubMed Central

Treatment-Resistant Schizophrenia: Treatment Response and Resistance in Psychosis (TRRIP) Working Group Consensus Guidelines on Diagnosis and Terminology (English)

1 reference

Europe PubMed Central

PubMed publication ID

8 September 2017

1 reference

based on heuristic

inferred from title

1 reference

based on heuristic

inferred from title

Birte Yding Glenthøj

23

object named as

Birte Y Glenthøj

1 reference

Europe PubMed Central

PubMed publication ID

8 September 2017

Ariel Graff-Guerrero

24

object named as

Ariel Graff-Guerrero

0 references

Tiago Reis Marques

object named as

Tiago Reis Marques

38

0 references

object named as

Fiona Gaughran

22

0 references

Richard J. Drake

object named as

Richard J Drake

15

0 references

object named as

Iris E Sommer

44

0 references

James H. MacCabe

object named as

James H MacCabe

32

0 references

object named as

David Taylor

45

0 references

object named as

Peter Falkai

19

0 references

object named as

Neil Thomas

46

0 references

Stephen M Lawrie

object named as

Stephen M Lawrie

29

0 references

Hans-Jürgen Möller

35

object named as

Hans-Jürgen Möller

1 reference

Europe PubMed Central

PubMed publication ID

8 September 2017

39

object named as

Gary Remington

1 reference

Europe PubMed Central

PubMed publication ID

8 September 2017

3

object named as

Ofer Agid

1 reference

Europe PubMed Central

PubMed publication ID

8 September 2017

Christos Pantelis

37

object named as

Christos Pantelis

1 reference

Europe PubMed Central

PubMed publication ID

8 September 2017

Zafiris J Daskalakis

13

object named as

Zafiris J Daskalakis

1 reference

Europe PubMed Central

PubMed publication ID

8 September 2017

Bjørn H Ebdrup

17

object named as

Bjørn H Ebdrup

1 reference

Europe PubMed Central

PubMed publication ID

8 September 2017

21

object named as

Ary Gadelha

1 reference

Europe PubMed Central

PubMed publication ID

8 September 2017

Jaime Eduardo Cecilio Hallak

25

object named as

Jaime E C Hallak

1 reference

Europe PubMed Central

PubMed publication ID

8 September 2017

Robert W. Buchanan

9

object named as

Robert W Buchanan

1 reference

Europe PubMed Central

PubMed publication ID

8 September 2017

Christoph Correll

51

object named as

Christoph U Correll

1 reference

Europe PubMed Central

PubMed publication ID

8 September 2017

Herbert Y. Meltzer

34

object named as

Herbert Meltzer

0 references

James L. Kennedy

27

object named as

James Kennedy

0 references

40

object named as

Susan L Rossell

1 reference

Europe PubMed Central

PubMed publication ID

8 September 2017

Takefumi Suzuki

43

object named as

Takefumi Suzuki

1 reference

Europe PubMed Central

PubMed publication ID

8 September 2017

Carolyn Beth McNabb

object named as

Carolyn B McNabb

33

0 references

Bruce R Russell

object named as

Bruce R Russell

41

0 references

12

object named as

Leslie Citrome

1 reference

Europe PubMed Central

PubMed publication ID

8 September 2017

50

object named as

John Kane

1 reference

Europe PubMed Central

PubMed publication ID

8 September 2017

author name string

Oliver D Howes

1

1 reference

Europe PubMed Central

PubMed publication ID

8 September 2017

Rob McCutcheon

2

1 reference

Europe PubMed Central

PubMed publication ID

8 September 2017

Andrea de Bartolomeis

4

1 reference

Europe PubMed Central

PubMed publication ID

8 September 2017

Nico J M van Beveren

5

1 reference

Europe PubMed Central

PubMed publication ID

8 September 2017

Michael L Birnbaum

6

1 reference

Europe PubMed Central

PubMed publication ID

8 September 2017

Michael A P Bloomfield

7

1 reference

Europe PubMed Central

PubMed publication ID

8 September 2017

Rodrigo A Bressan

8

1 reference

Europe PubMed Central

PubMed publication ID

8 September 2017

William T Carpenter

10

1 reference

Europe PubMed Central

PubMed publication ID

8 September 2017

David J Castle

11

1 reference

Europe PubMed Central

PubMed publication ID

8 September 2017

Michael Davidson

14

1 reference

Europe PubMed Central

PubMed publication ID

8 September 2017

Serdar Dursun

16

1 reference

Europe PubMed Central

PubMed publication ID

8 September 2017

Helio Elkis

18

1 reference

Europe PubMed Central

PubMed publication ID

8 September 2017

W Wolfgang Fleischacker

20

1 reference

Europe PubMed Central

PubMed publication ID

8 September 2017

William G Honer

26

1 reference

Europe PubMed Central

PubMed publication ID

8 September 2017

Bruce J Kinon

28

1 reference

Europe PubMed Central

PubMed publication ID

8 September 2017

Jimmy Lee

30

1 reference

Europe PubMed Central

PubMed publication ID

8 September 2017

F Markus Leweke

31

1 reference

Europe PubMed Central

PubMed publication ID

8 September 2017

Shinchiro Nakajima

36

1 reference

Europe PubMed Central

PubMed publication ID

8 September 2017

Cynthia O Siu

42

1 reference

Europe PubMed Central

PubMed publication ID

8 September 2017

Alp Üçok

47

1 reference

Europe PubMed Central

PubMed publication ID

8 September 2017

Daniel Umbricht

48

1 reference

Europe PubMed Central

PubMed publication ID

8 September 2017

James T R Walters

49

1 reference

Europe PubMed Central

PubMed publication ID

8 September 2017

language of work or name

0 references

publication date

6 December 2016

1 reference

Europe PubMed Central

PubMed publication ID

8 September 2017

American Journal of Psychiatry

1 reference

Europe PubMed Central

PubMed publication ID

8 September 2017

174

1 reference

Europe PubMed Central

PubMed publication ID

8 September 2017

3

1 reference

Europe PubMed Central

PubMed publication ID

8 September 2017

216-229

1 reference

Europe PubMed Central

PubMed publication ID

8 September 2017

An algorithm-based approach to first-episode schizophrenia: response rates over 3 prospective antipsychotic trials with a retrospective data analysis

1 reference

https://pubmed.ncbi.nlm.nih.gov/27919182

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

A systematic review of the evidence of clozapine's anti-aggressive effects.

1 reference

https://pubmed.ncbi.nlm.nih.gov/27919182

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Relationships among subjective and objective measures of adherence to oral antipsychotic medications

1 reference

https://pubmed.ncbi.nlm.nih.gov/27919182

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Time to clozapine response in a standardized trial

1 reference

https://pubmed.ncbi.nlm.nih.gov/27919182

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Clozapine and therapeutic drug monitoring: is there sufficient evidence for an upper threshold?

1 reference

https://pubmed.ncbi.nlm.nih.gov/27919182

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Royal Australian and New Zealand College of Psychiatrists clinical practice guidelines for the treatment of schizophrenia and related disorders

1 reference

https://pubmed.ncbi.nlm.nih.gov/27919182

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Efficacy of pharmacotherapy and psychotherapy for adult psychiatric disorders: a systematic overview of meta-analyses.

1 reference

https://pubmed.ncbi.nlm.nih.gov/27919182

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Defining treatment refractoriness in schizophrenia

1 reference

https://pubmed.ncbi.nlm.nih.gov/27919182

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Past and present progress in the pharmacologic treatment of schizophrenia

1 reference

https://pubmed.ncbi.nlm.nih.gov/27919182

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

International consensus study of antipsychotic dosing.

1 reference

https://pubmed.ncbi.nlm.nih.gov/27919182

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Comparison of treatment response in second-episode versus first-episode schizophrenia

1 reference

https://pubmed.ncbi.nlm.nih.gov/27919182

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Computerized assessment of cognition in schizophrenia: promises and pitfalls of CANTAB.

1 reference

https://pubmed.ncbi.nlm.nih.gov/27919182

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Defining treatment-resistant schizophrenia and response to antipsychotics: a review and recommendation

1 reference

https://pubmed.ncbi.nlm.nih.gov/27919182

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

A neurobiological hypothesis for the classification of schizophrenia: type A (hyperdopaminergic) and type B (normodopaminergic).

1 reference

https://pubmed.ncbi.nlm.nih.gov/27919182

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Olanzapine versus clozapine in treatment-resistant or treatment-intolerant schizophrenia

1 reference

https://pubmed.ncbi.nlm.nih.gov/27919182

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Adherence to treatment guidelines in clinical practice: study of antipsychotic treatment prior to clozapine initiation

1 reference

https://pubmed.ncbi.nlm.nih.gov/27919182

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

The Brief Assessment of Cognition in Schizophrenia: reliability, sensitivity, and comparison with a standard neurocognitive battery.

1 reference

https://pubmed.ncbi.nlm.nih.gov/27919182

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Healthy individuals with auditory verbal hallucinations; who are they? Psychiatric assessments of a selected sample of 103 subjects.

1 reference

https://pubmed.ncbi.nlm.nih.gov/27919182

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Efficacy and safety of individual second-generation vs. first-generation antipsychotics in first-episode psychosis: a systematic review and meta-analysis

1 reference

https://pubmed.ncbi.nlm.nih.gov/27919182

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

What is an adequate trial with clozapine?: therapeutic drug monitoring and time to response in treatment-refractory schizophrenia

1 reference

https://pubmed.ncbi.nlm.nih.gov/27919182

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Treatment resistant schizophrenia and response to antipsychotics: a review

1 reference

https://pubmed.ncbi.nlm.nih.gov/27919182

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

The Role of Clozapine in Treatment-Resistant Schizophrenia

1 reference

https://pubmed.ncbi.nlm.nih.gov/27919182

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Measurements of response, remission, and recovery in schizophrenia and examples for their clinical application.

1 reference

https://pubmed.ncbi.nlm.nih.gov/27919182

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Predictors of clinical outcome in schizophrenic patients responding to clozapine

1 reference

https://pubmed.ncbi.nlm.nih.gov/27919182

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

The Positive and Negative Syndrome Scale and the Brief Psychiatric Rating Scale. Reliability, comparability, and predictive validity.

1 reference

https://pubmed.ncbi.nlm.nih.gov/27919182

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

A meta-analysis of head-to-head comparisons of second-generation antipsychotics in the treatment of schizophrenia

1 reference

https://pubmed.ncbi.nlm.nih.gov/27919182

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Atypical and Conventional Antipsychotic Drugs in Treatment-Naive First-Episode Schizophrenia: A 52-Week Randomized Trial of Clozapine Vs Chlorpromazine

1 reference

https://pubmed.ncbi.nlm.nih.gov/27919182

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Social functioning and the course of early-onset schizophrenia: five-year follow-up of a psychosocial intervention

1 reference

https://pubmed.ncbi.nlm.nih.gov/27919182

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Clozapine treatment of outpatients with schizophrenia: outcome and long-term response patterns. 1993.

1 reference

https://pubmed.ncbi.nlm.nih.gov/27919182

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Linking the PANSS, BPRS, and CGI: clinical implications

1 reference

https://pubmed.ncbi.nlm.nih.gov/27919182

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Dose Equivalents for Second-Generation Antipsychotic Drugs: The Classical Mean Dose Method

1 reference

https://pubmed.ncbi.nlm.nih.gov/27919182

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Clozapine plasma level monitoring: current status

1 reference

https://pubmed.ncbi.nlm.nih.gov/27919182

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Quantifying clinical relevance in the treatment of schizophrenia

1 reference

https://pubmed.ncbi.nlm.nih.gov/27919182

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Comparative efficacy and tolerability of 15 antipsychotic drugs in schizophrenia: a multiple-treatments meta-analysis

1 reference

https://pubmed.ncbi.nlm.nih.gov/27919182

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

AGNP Consensus Guidelines for Therapeutic Drug Monitoring in Psychiatry: Update 2011.

1 reference

https://pubmed.ncbi.nlm.nih.gov/27919182

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Medication adherence in outpatients with severe mental disorders: relation between self-reports and serum level.

1 reference

https://pubmed.ncbi.nlm.nih.gov/27919182

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

The positive and negative syndrome scale (PANSS) for schizophrenia

1 reference

https://pubmed.ncbi.nlm.nih.gov/27919182

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Insight in Schizophrenia: A Review

1 reference

https://pubmed.ncbi.nlm.nih.gov/27919182

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

A prospective study of clozapine in treatment-resistant schizophrenic patients. I. Preliminary report.

1 reference

https://pubmed.ncbi.nlm.nih.gov/27919182

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Natural course of schizophrenic disorders: a 15-year followup of a Dutch incidence cohort.

1 reference

https://pubmed.ncbi.nlm.nih.gov/27919182

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Ministry of Health clinical practice guidelines: schizophrenia

1 reference

https://pubmed.ncbi.nlm.nih.gov/27919182

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

A quantitative review of the profile and time course of symptom change in schizophrenia treated with clozapine.

1 reference

https://pubmed.ncbi.nlm.nih.gov/27919182

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Dose equivalents for second-generation antipsychotics: the minimum effective dose method

1 reference

https://pubmed.ncbi.nlm.nih.gov/27919182

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

New second-generation long-acting injectable antipsychotics for the treatment of schizophrenia

1 reference

https://pubmed.ncbi.nlm.nih.gov/27919182

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Pharmacotherapy for treatment-refractory schizophrenia

1 reference

https://pubmed.ncbi.nlm.nih.gov/27919182

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Efficacy, Acceptability, and Tolerability of Antipsychotics in Treatment-Resistant Schizophrenia: A Network Meta-analysis

1 reference

https://pubmed.ncbi.nlm.nih.gov/27919182

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Do you want chips with that?

1 reference

https://pubmed.ncbi.nlm.nih.gov/27919182

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Compliance in clinical trials

1 reference

https://pubmed.ncbi.nlm.nih.gov/27919182

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Schizophrenia: an integrated sociodevelopmental-cognitive model

1 reference

https://pubmed.ncbi.nlm.nih.gov/27919182

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Assessing levels of adaptive functioning: the Role Functioning Scale

1 reference

https://pubmed.ncbi.nlm.nih.gov/27919182

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

The Clinical Global Impression-Schizophrenia scale: a simple instrument to measure the diversity of symptoms present in schizophrenia

1 reference

https://pubmed.ncbi.nlm.nih.gov/27919182

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Practice guideline for the treatment of patients with schizophrenia, second edition.

1 reference

https://pubmed.ncbi.nlm.nih.gov/27919182

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Randomized controlled trial of interventions designed to reduce the risk of progression to first-episode psychosis in a clinical sample with subthreshold symptoms

1 reference

https://pubmed.ncbi.nlm.nih.gov/27919182

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

The role of long-acting injectable antipsychotics in schizophrenia: a critical appraisal.

1 reference

https://pubmed.ncbi.nlm.nih.gov/27919182

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Clozapine v. chlorpromazine in treatment-naive, first-episode schizophrenia: 9-year outcomes of a randomised clinical trial.

1 reference

https://pubmed.ncbi.nlm.nih.gov/27919182

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

World Federation of Societies of Biological Psychiatry (WFSBP) guidelines for biological treatment of schizophrenia, Part 1: acute treatment of schizophrenia

1 reference

https://pubmed.ncbi.nlm.nih.gov/27919182

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

The clinical use of plasma clozapine levels.

1 reference

https://pubmed.ncbi.nlm.nih.gov/27919182

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

How long to wait for a response to clozapine: a comparison of time course of response to clozapine and conventional antipsychotic medication in refractory schizophrenia

1 reference

https://pubmed.ncbi.nlm.nih.gov/27919182

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

The natural history and pathophysiology of treatment resistant schizophrenia

1 reference

https://pubmed.ncbi.nlm.nih.gov/27919182

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Mechanisms underlying psychosis and antipsychotic treatment response in schizophrenia: insights from PET and SPECT imaging.

1 reference

https://pubmed.ncbi.nlm.nih.gov/27919182

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Time course for antipsychotic treatment response in first-episode schizophrenia

1 reference

https://pubmed.ncbi.nlm.nih.gov/27919182

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Schizophrenia with good and poor outcome. I: Early clinical features, response to neuroleptics and signs of organic dysfunction

1 reference

https://pubmed.ncbi.nlm.nih.gov/27919182

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Pharmacokinetics and pharmacodynamics of clozapine

1 reference

https://pubmed.ncbi.nlm.nih.gov/27919182

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

The risks and benefits of clozapine versus chlorpromazine

1 reference

https://pubmed.ncbi.nlm.nih.gov/27919182

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Treatment response after relapse in a placebo-controlled maintenance trial in schizophrenia

1 reference

https://pubmed.ncbi.nlm.nih.gov/27919182

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Subtyping Schizophrenia by Treatment Response: Antipsychotic Development and the Central Role of Positive Symptoms

1 reference

https://pubmed.ncbi.nlm.nih.gov/27919182

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Evidence-based guidelines for the pharmacological treatment of schizophrenia: recommendations from the British Association for Psychopharmacology

1 reference

https://pubmed.ncbi.nlm.nih.gov/27919182

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Optimising treatment of refractory schizophrenia

1 reference

https://pubmed.ncbi.nlm.nih.gov/27919182

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Dopamine synthesis capacity in patients with treatment-resistant schizophrenia

1 reference

https://pubmed.ncbi.nlm.nih.gov/27919182

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

A brief mental health outcome scale-reliability and validity of the Global Assessment of Functioning (GAF).

1 reference

https://pubmed.ncbi.nlm.nih.gov/27919182

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Antipsychotic treatment resistance in schizophrenia associated with elevated glutamate levels but normal dopamine function.

1 reference

https://pubmed.ncbi.nlm.nih.gov/27919182

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Dopaminergic function in the psychosis spectrum: an [18F]-DOPA imaging study in healthy individuals with auditory hallucinations

1 reference

https://pubmed.ncbi.nlm.nih.gov/27919182

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Is the PANSS used correctly? a systematic review.

1 reference

https://pubmed.ncbi.nlm.nih.gov/27919182

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Clozapine for the treatment of schizophrenia

1 reference

https://pubmed.ncbi.nlm.nih.gov/27919182

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

History of the discovery and clinical introduction of chlorpromazine

1 reference

https://pubmed.ncbi.nlm.nih.gov/27919182

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Development, reliability and acceptability of a new version of the DSM-IV Social and Occupational Functioning Assessment Scale (SOFAS) to assess routine social functioning

1 reference

https://pubmed.ncbi.nlm.nih.gov/27919182

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Modeling the early course of schizophrenia

1 reference

https://pubmed.ncbi.nlm.nih.gov/27919182

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Treatment resistant or resistant to treatment? Antipsychotic plasma levels in patients with poorly controlled psychotic symptoms

1 reference

https://pubmed.ncbi.nlm.nih.gov/27919182

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Is the time course of clozapine response correlated to the time course of clozapine plasma levels? A one-year prospective study in drug-resistant patients with schizophrenia.

1 reference

https://pubmed.ncbi.nlm.nih.gov/27919182

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Clozapine versus typical neuroleptic medication for schizophrenia

1 reference

https://pubmed.ncbi.nlm.nih.gov/27919182

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Clinical effects of clozapine in chronic schizophrenia: response to treatment and predictors of outcome

1 reference

https://pubmed.ncbi.nlm.nih.gov/27919182

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Clozapine for the treatment-resistant schizophrenic. A double-blind comparison with chlorpromazine

1 reference

https://pubmed.ncbi.nlm.nih.gov/27919182

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Olanzapine treatment of residual positive and negative symptoms

1 reference

https://pubmed.ncbi.nlm.nih.gov/27919182

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Delayed-onset hypothesis of antipsychotic action: a hypothesis tested and rejected

1 reference

https://pubmed.ncbi.nlm.nih.gov/27919182

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Non-adherence to medication in patients with psychotic disorders: epidemiology, contributing factors and management strategies

1 reference

https://pubmed.ncbi.nlm.nih.gov/27919182

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.1176/APPI.AJP.2016.16050503

1 reference

Europe PubMed Central

PubMed publication ID

8 September 2017

PMC publication ID

0 references

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

8 September 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q39029626&oldid=2098974045"